The role of data-driven insights in shaping inclusive cancer clinical trials: an interview with Neal Meropol, Flatiron Health

The traditional model of clinical trials, while essential, often faces challenges in representing diverse patient populations and real-world scenarios. Recent advancements highlighted in an article published in NEJM Evidence emphasize the potential of real-world data (RWD) to bridge these gaps. By integrating RWD, researchers can enhance the inclusivity and applicability of clinical trials, ensuring that the benefits of new treatments are accessible to a broader range of patients. In this interview with Neal Meropol, Vice President of Research Oncology at Flatiron Health, we explore how these data-driven approaches are transforming oncology trials, improving patient outcomes, and addressing disparities in health...